Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Robert Altman
Person

Robert Altman

Overview

Edit Overview Section
Number of Current Board & Advisor Roles 1
Number of Founded Organizations 3
Robert Altman is the Founder and Member Board Of Directors of Toltec Pharmaceuticals.

Jobs

Edit Jobs Section
Number of Past Jobs 3
Robert Altman has had 3 past jobs including President at Pinnacle Biologics.
Organization Name  
Title At Company  
Start Date  
End Date  
Pinnacle Biologics Logo
Pinnacle Biologics
PresidentDec 2013Aug 2015
Pinnacle Biologics Logo
Pinnacle Biologics
Chief Commercial OfficerJun 2012Dec 2013
Marathon Pharmaceuticals Logo
Marathon Pharmaceuticals
Founder & CEONov 2007May 2012

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 1
Robert Altman is the Founder and Member of the Board of Directors at Toltec Pharmaceuticals.

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Greater Chicago Area Biotechnology Companies Logo
Greater Chicago Area Biotechnology Companies
51,451
Illinois Therapeutics Companies Logo
Illinois Therapeutics Companies
51,082
Great Lakes Therapeutics Companies Logo
Great Lakes Therapeutics Companies
18,129
Greater Chicago Area Therapeutics Companies Logo
Greater Chicago Area Therapeutics Companies
53,983
Illinois Biotechnology Companies Logo
Illinois Biotechnology Companies
46,353
Midwestern US Therapeutics Companies Logo
Midwestern US Therapeutics Companies
22,097

Education

Edit Education Section
Robert Altman studied at The University of Chicago Booth School of Business.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 16
News•Feb 13, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 8, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 6, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 18, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 5, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 26, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 22, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 12, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 28, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 30, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
View All
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(882d4b2 1)
|